How is the Lipocine Inc today?

The Lipocine Inc today is trading in the down by -1.66% at 3.56.

What is Lipocine Inc Annual Revenue?

Lipocine Inc Annual Revenue rose 492.8%, in the last year to $11.2 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Lipocine Inc Annual Net Profit?

Lipocine Inc Annual Net Profit rose 100.05% in the last year to $0.01 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Lipocine Inc Price to Earning Ratio?

Lipocine Inc Price to Earning Ratio is -3.55, which is negative.

What is Lipocine Inc Stock Price?

Lipocine Inc Stock Price fell 45.81% and underperformed its sector by 57.19% in the past year.

What is Lipocine Inc Quarterly Revenue?

Lipocine Inc Quarterly Revenue fell 98.77% YoY to $0.09 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Lipocine Inc Quarterly Net profit?

Lipocine Inc Quarterly Net profit fell 153.08% YoY to $1.86 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Lipocine Inc Return on Equity(ROE)?

Lipocine Inc Return on Equity(ROE) for the last financial year was 0.04%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Lipocine Inc Mutual Fund Holding?

Lipocine Inc Mutual Fund Holding increased by 0.12% in the last quarter to 11.05.

What is Lipocine Inc Promoter Share Holding?

Lipocine Inc Promoter Share Holding stayed the same in the most recent quarter at 1.74%.

What is Lipocine Inc Institutional Holding?

Lipocine Inc Institutional Holding increased by 0.2% in the last quarter to 10.

Lipocine Inc XNAS: LPCN

Lipocine Inc Live Share Price Today, Share Analysis and Chart

Name: Lipocine Inc: Is Infosys Ltd. worth buying?
Item: Lipocine Inc
Rating: 1.68791675
Author: Trendlyne DVM scores

about

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing dr...

3.56 -0.06 (-1.66%)

69.80% Fall from 52W High

25,417 XNAS Volume

High vol.+gain this week

XNAS 22 May, 2025 2:34 PM (EDT)

Not Eligible

-

Expensive Valuation

19.2 / 100

Technically Neutral

48.4 / 100

7

1Yr Price target upside is 90%

1 analysts

Lipocine Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lipocine Inc FAQ

How is Lipocine Inc today?

Lipocine Inc today is trading in the red, and is down by -1.66% at 3.56.

How has Lipocine Inc performed historically?

Lipocine Inc is currently trading down -1.66% on an intraday basis. In the past week the stock rose 12.66%. stock has been up 5.33% in the past quarter and fell -45.81% in the past year. You can view this in the overview section.